Chief Executive Officer of Hengrui USA & Hengrui Europe
Scott is responsible for Hengrui's businesses in the United States and Europe. Scott is an outstanding business leader with over 25 years of successful pharmaceutical leadership experience across multiple therapeutic areas including oncology, immunology, neuroscience, rare diseases, targeted therapies and specialty pharmaceuticals. He has extensive experience in end-to-end commercial and other areas, including sales, marketing, operations, access, patient services and country managing director both in the U.S. and globally. Scott is joining Hengrui from Merck KGaA, EMD Serono where he served as Chief Commercial Officer for the US where his teams successfully launched multiple new medicines.
Scott, who received his bachelor's degree from Fitchburg State University in Massachusetts, held positions of increasing responsibility at Johnson & Johnson, Boehringer Ingelheim and UCB from 1993 to 2005 before joining Merck KGaA where he led Global Market Access and served as Chief Commercial Officer.